Metabolic syndrome in hypertensive patients

Abstract

Clustering of metabolic syndrome (MS) components induces pathological events, which may amplify hypertension (HTN) -related cardiac and renal changes over and above the potential risk of each risk factor in isolation. To shed light on such clustering of risk factors in hypertension patients. Ninety one hypertensive patients were enrolled in the study compared with (31) apparently healthy normotensive individuals. Anthropometric measurements and metabolic profiles were evaluated in both groups. Waist to height ratio was noticed to be the highest recordable factor in hypertensive patients as a major cardiometabolic risk factor, accompanied by metabolic derangement including elevated fasting blood glucose, serum triglyceride, which was clearly manifested in patients group. MS related to obesity may participate in exacerbation of pathological events leading to hard management of hypertension related complications. The clustering effects of MS component among HTN patients should be considered in therapeutic strategies.